0 Comments
0 Shares
304 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Intravenous Immunoglobulin Market Shifts in Procurement StrategiesThe global intravenous immunoglobulin (IVIG) market was valued at USD 14.9 billion in 2025 and is expected to reach USD 25.7 billion by 2033, expanding at a 7.0% CAGR from 2026 to 2033. The market is projected to increase from USD 16.0 billion in 2026. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is expected to register the fastest growth during the...0 Comments 0 Shares 84 Views 0 Reviews
-
Intravenous Immunoglobulin Market Trends in Clinical Evidence GenerationThe global intravenous immunoglobulin (IVIG) market was valued at USD 14.9 billion in 2025 and is expected to reach USD 25.7 billion by 2033, expanding at a 7.0% CAGR from 2026 to 2033. The market is forecast to increase from USD 16.0 billion in 2026. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is anticipated to register the fastest growth during...0 Comments 0 Shares 90 Views 0 Reviews
-
Intravenous Immunoglobulin Market: Chronic Conditions Sustain DemandThe global intravenous immunoglobulin market was valued at USD 14.9 billion in 2025 and is expected to reach USD 16.0 billion in 2026, rising to USD 25.7 billion by 2033. The market is projected to expand at a 7.0% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is anticipated to register the fastest growth during the forecast...0 Comments 0 Shares 87 Views 0 Reviews
-
U.S. Intravenous Immunoglobulin Market Sees Investment in Plasma NetworksThe U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a 7.7% CAGR from 2023 to 2030. Growth is being supported by increasing demand for immunoglobulin replacement therapy among patients with Primary Immunodeficiency Diseases (PIDD), along with the approval of new IVIG products that are broadening available treatment options. What...0 Comments 0 Shares 126 Views 0 Reviews
-
U.S. Intravenous Immunoglobulin Market Trends in Supply Chain ResilienceThe U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. Rising demand for immunoglobulin replacement therapy, particularly for primary immunodeficiency diseases (PIDD), and the introduction of new products are supporting market growth. Expanded treatment options,...0 Comments 0 Shares 80 Views 0 Reviews
-
IVIg Market Report: Market Share, Regional Growth Patterns, and Key Manufacturer ProfilesIntravenous Immunoglobulin (IVIg) Market Demand and Global Outlook The Intravenous Immunoglobulin (IVIg) Market is experiencing strong demand due to rising prevalence of immune-related disorders and increased adoption of IVIg therapy in hospitals and clinics worldwide. MRFR reports that growing awareness among healthcare professionals and patients is accelerating adoption, while manufacturers...0 Comments 0 Shares 332 Views 0 Reviews
-
Neonatal Jaundice IVIG Market Size, Trends and Growth- 2032According to the latest report published by Data Bridge Market Research, the Neonatal Jaundice Intravenous Immunoglobulin Market size is projected to grow from USD 24.46 Million in 2024 to USD 39.84 Million by 2032, exhibiting a CAGR of 6.29% during the forecast period 2025 - 2032. Global Neonatal Jaundice Intravenous Immunoglobulin Market document gives important, thoughtful and...0 Comments 0 Shares 75 Views 0 Reviews